BC
BDSI

Brinker Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Brinker Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$922K Buy
211,395
+4,014
+2% +$18K 0.03% 521
2020
Q1 		$786K Buy
207,381
+49,884
+32% +$245K 0.03% 501
2019
Q4 		$995K Buy
157,497
+58,000
+58% +$341K 0.03% 509
2019
Q3 		$419K Buy
+99,497
New +$425K 0.01% 738

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Brinker Capital's BDSI Position: Q2 2020 in Review

Brinker Capital increased its BioDelivery Sciences International, Inc. (BDSI) stake by 1.9% in Q2 2020, buying an estimated $18K and bringing the position to 211,395 shares worth $922K. The position accounts for 0.03% of the portfolio, ranked #521.

Brinker Capital first reported a position in BDSI in Q3 2019 and has held it in 4 quarters since. The position peaked at $995K in Q4 2019. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • Brinker Capital held 211,395 shares of BioDelivery Sciences International, Inc. worth $922K as of Q2 2020.
  • Brinker Capital bought 4,014 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $18K.
  • BioDelivery Sciences International, Inc. made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #521 holding.
  • Brinker Capital first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and has held it in 4 quarters since.
  • Brinker Capital's BioDelivery Sciences International, Inc. position peaked at $995K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.